[
  {
    "ts": "2026-02-03T01:42:45+00:00",
    "headline": "Abbott Laboratories (ABT): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Abbott Laboratories on R. Dennis’s SubstackR. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on ABT. Abbott Laboratories’s share was trading at $106.09 as of January 29th. ABT’s trailing and forward P/E were 28.52 and 18.69 respectively according to Yahoo Finance. Abbott Laboratories, together with its […]",
    "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-bull-case-014245352.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "4ab5ebfb-4b8e-3d7f-92f0-442b6cd21f4d",
      "content": {
        "id": "4ab5ebfb-4b8e-3d7f-92f0-442b6cd21f4d",
        "contentType": "STORY",
        "title": "Abbott Laboratories (ABT): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on Abbott Laboratories on R. Dennis’s SubstackR. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on ABT. Abbott Laboratories’s share was trading at $106.09 as of January 29th. ABT’s trailing and forward P/E were 28.52 and 18.69 respectively according to Yahoo Finance. Abbott Laboratories, together with its […]",
        "pubDate": "2026-02-03T01:42:45Z",
        "displayTime": "2026-02-03T01:42:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/5ebeb797976f4b134f89e7fc0f1f7cd5",
          "originalWidth": 848,
          "originalHeight": 565,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qjhajy_X8xr_FpnwS8Zrgg--~B/aD01NjU7dz04NDg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5ebeb797976f4b134f89e7fc0f1f7cd5.cf.webp",
              "width": 848,
              "height": 565,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5LsSqgRtcwqY7UZvRa9m3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5ebeb797976f4b134f89e7fc0f1f7cd5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-bull-case-014245352.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-bull-case-014245352.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "NECPY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]